Mitochondrial bound type II hexokinase: a key player in the growth and survival of many cancers and an ideal prospect for therapeutic interventionPeter L. Pedersen, Young Hee Ko, J.F. Geschwind et al.|Biochimica et Biophysica Acta (BBA) - Bioenergetics|2002Cited by 350
Glucose catabolism in the rabbit VX2 tumor model for liver cancer: characterization and targeting hexokinaseYoung Hee Ko, J.F. Geschwind, Peter L. Pedersen|Cancer Letters|2001Cited by 346
Novel therapy for liver cancer: direct intraarterial injection of a potent inhibitor of ATP production.J.F. Geschwind, Peter L. Pedersen, Young Hee Ko et al.|PubMed|2002Cited by 257
Ca2+ responses to interleukin 1 and tumor necrosis factor in cultured human skin fibroblasts. Possible implications for Reye syndrome.Barbara E. Corkey, Laurie E. Kilpatrick, J.F. Geschwind et al.|Journal of Clinical Investigation|1991Cited by 41